Markets:

Overview

News

Currencies

International

Treasuries

Jasper Therapeutics, Inc. - Class A Common Stock (NQ:JSPR)

1.432 -0.148 (-9.39%)

Streaming Delayed Price Updated: 11:58 AM EST, Dec 3, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Jasper Therapeutics, Inc. - Class A Common Stock

< Previous 1 2 3 4 5 Next >

These stocks are moving in today's pre-market session ↗

December 02, 2025

Before the opening bell on Tuesday, let's take a glimpse of the US markets and explore the top gainers and losers in today's pre-market session.

Via Chartmill

What's going on in today's after hours session ↗

December 01, 2025

After the conclusion of the US market's regular session on Monday, let's examine the after-hours session and unveil the notable performers among the top gainers and losers.

Via Chartmill

CoreWeave Bulls Should Brace For 'Wild, Lumpy, Volatile Ride,' JPMorgan Says ↗

November 11, 2025

JPMorgan downgrades CoreWeave, citing turbulence in AI infrastructure market. Despite near-term challenges, long-term growth...

Via Benzinga

Topics Artificial Intelligence

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

September 24, 2025

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

September 19, 2025

Via Benzinga

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

September 18, 2025

Via Benzinga

Stay updated with the stocks that are on the move in today's after-hours session. ↗

September 18, 2025

After the closing bell on Thursday, let's take a glimpse of the US markets and explore the top gainers and losers in today's after-hours session.

Via Chartmill

Jasper Reports Wider Loss in Fiscal Q2 ↗

August 13, 2025

Via The Motley Fool

Jasper Therapeutics Gets Hit With Downgrades Over Faulty Batch Of Skin Allergy Drug; Retail Sees ‘Overreaction’ ↗

July 08, 2025

The company flagged that 10 of 13 patients in two dosing cohorts received a compromised batch of briquilimab, leading to muted results.

Via Stocktwits

Top stock movements in today's session. ↗

July 07, 2025

Curious to know what's happening on the US markets one hour before the close of the markets on Monday? Join us as we explore the top gainers and losers in today's session.

Via Chartmill

Jasper Therapeutics Shares Fall On Briquilimab Drug Lot Problem ↗

July 07, 2025

Jasper shares drop after updated BEACON study shows strong results but faces disruption from compromised drug product lot and halted pipeline programs.

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

July 07, 2025

Via Benzinga

Dow Dips 1%; Mustang Bio Shares Spike Higher ↗

July 07, 2025

Via Benzinga

Topics Stocks

Here are the top movers in Monday's session. ↗

July 07, 2025

Let's have a look at what is happening on the US markets in the middle of the day on Monday. Below you can find the top gainers and losers in today's session.

Via Chartmill

Let's uncover which stocks are experiencing notable gaps during today's session. ↗

July 07, 2025

Today's session on Monday is marked by notable gaps in various stocks. Stay informed with the gap up and gap down stocks in today's session.

Via Chartmill

Nasdaq Falls Over 100 Points; Capgemini To Acquire WNS ↗

July 07, 2025

Via Benzinga

What's going on in today's pre-market session ↗

July 07, 2025

Wondering what's happening in Monday's pre-market session? Find an overview in this article.

Via Chartmill

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

July 07, 2025

Via Benzinga

Russell 2000 Index Forecast As The Crash Continues: Buy The Dip? ↗

April 22, 2025

The Russell 2000 Index has plunged and formed a death cross this year as American stocks sink amid rising worries about Donald Trump’s policies.

Via Talk Markets

Topics Government Stocks / Equities

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

January 08, 2025

Via Benzinga

Crude Oil Down 1%; US Weekly Jobless Claims Decline ↗

January 08, 2025

Via Benzinga

Jasper Therapeutics Skin Disorder Candidate Data Fails To Cheer Investors ↗

January 08, 2025

Jasper Therapeutics reports strong briquilimab efficacy in CSU with UAS7 reductions, dose-dependent responses, and Phase 2b plans by late 2025.

Via Benzinga

US Stocks Down; Acuity Brands Posts Weak Revenue ↗

January 08, 2025

Via Benzinga

Futures Slump As Yields, Dollar Soar ↗

January 08, 2025

In premarket trading Quantum stocks tumbled after Nvidia CEO Jensen Huang said that “very useful” quantum computers are likely decades away.

Via Talk Markets

Topics Commodities Stocks / Equities

Why Is Chronic Disease-Focused Jasper Therapeutics Stock Trading Higher On Monday? ↗

October 14, 2024

Jasper Therapeutics' SPOTLIGHT study reports 93% clinical response in cold urticaria and symptomatic dermographism. The 120mg dose showed 83% complete response and no severe adverse events. Full data...

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

October 14, 2024

Via Benzinga

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

October 09, 2024

Via Benzinga

JSPR Stock Earnings: Jasper Therapeutics Beats EPS for Q2 2024 ↗

August 13, 2024

JSPR stock results show that Jasper Therapeutics beat analyst estimates for earnings per share the second quarter of 2024.

Via InvestorPlace

JSPR Stock Earnings: Jasper Therapeutics Beats EPS for Q1 2024 ↗

May 14, 2024

JSPR stock results show that Jasper Therapeutics beat analyst estimates for earnings per share the first quarter of 2024.

Via InvestorPlace

Why Jabil Shares Are Trading Lower By 8%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

June 20, 2024

Via Benzinga

< Previous 1 2 3 4 5 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.